Author Correction: Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B.

Autor: Musella M; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Guarracino A; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.; Genomics Research Centre, Human Technopole, Milan, Italy., Manduca N; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Galassi C; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.; Department of Radiation Oncology, Weill Cornell Medical College, New York, NY, USA., Ruggiero E; Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Potenza A; Experimental Hematology Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy., Maccafeo E; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Manic G; Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy.; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Mattiello L; Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy.; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy., Soliman Abdel Rehim S; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy.; Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy., Signore M; RPPA Unit, Proteomics Area, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Pietrosanto M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Helmer-Citterich M; Department of Biology, University of Rome 'Tor Vergata', Rome, Italy., Pallocca M; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Fanciulli M; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Bruno T; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., De Nicola F; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Corleone G; SAFU Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Di Benedetto A; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Ercolani C; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Pescarmona E; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Pizzuti L; Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Guidi F; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.; Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy., Sperati F; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS San Gallicano Dermatological Institute, Rome, Italy., Vitale S; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Macchia D; Center of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy., Spada M; Center of Animal Research and Welfare, Istituto Superiore di Sanità, Rome, Italy., Schiavoni G; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Mattei F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., De Ninno A; Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy., Businaro L; Institute for Photonics and Nanotechnologies, Italian National Research Council, Rome, Italy., Lucarini V; Department of Paediatric Haematology/Oncology and of Cell and Gene Therapy, Ospedale Pediatrico Bambino Gesù, IRCCS, Rome, Italy., Bracci L; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Aricò E; FaBioCell, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Ziccheddu G; Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer Institute, Rome, Italy., Facchiano F; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Rossi S; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., Sanchez M; Cytometry Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Boe A; Cytometry Unit, Core Facilities, Istituto Superiore di Sanità, Rome, Italy., Biffoni M; Department of Oncology and Molecular Medicine, Istituto Superiore di Sanità, Rome, Italy., De Maria R; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. ruggero.demaria@unicatt.it.; Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. ruggero.demaria@unicatt.it., Vitale I; Italian Institute for Genomic Medicine (IIGM), Candiolo, Italy. ilio.vitale@gmail.com.; Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy. ilio.vitale@gmail.com., Sistigu A; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy. antonella.sistigu@unicatt.it.; Fondazione Policlinico Universitario 'A. Gemelli' - IRCCS, Rome, Italy. antonella.sistigu@unicatt.it.; Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. antonella.sistigu@unicatt.it.
Jazyk: angličtina
Zdroj: Nature immunology [Nat Immunol] 2024 Nov; Vol. 25 (11), pp. 2166.
DOI: 10.1038/s41590-024-01984-w
Databáze: MEDLINE